Here are the 10-K annual reports from Concentra Group Holdings Parent, Inc. (CON) in our archive since June 2025, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-K covers the audited annual report, with the full financial statements, so if you follow CON and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full CON filings page.
Concentra Group Holdings Parent, Inc. (CON) reported 2025 revenue of $2,163.4 million, up 13.9% from $1,900.2 million in 2024. Occupational health center patient visits increased 7.3% to 13,546,707, while revenue per visit rose 4.3% to $147.42. The company attributed revenue growth to higher visit volume and revenue per visit, and to acquisitions.
Concentra acquired Nova Medical Centers effective March 1, 2025, for a purchase price of $265.0 million, subject to adjustment, and Pivot Onsite Innovations effective June 1, 2025, for $54.4 million, subject to adjustment. Net income attributable to the company was $166.4 million versus $166.5 million; Adjusted EBITDA, a non-GAAP measure, was $431.9 million versus $376.9 million.
Net cash provided by operating activities was $279.4 million. Concentra repaid $85 million on its revolving credit facility, with no borrowings outstanding at year-end; the facility was increased to $450.0 million and the Term Loan to $950.0 million. It repurchased 1.1 million shares for $22.4 million in 2025; the program, authorized for up to $100 million, had $80.0 million remaining authorization as of December 31, 2025, and expires December 31, 2027 unless extended or terminated.